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Commitment of progenitors in the dermomyotome to myoblast
fate is the ﬁrst step in establishing the body musculature. Pax3 is a
crucial transcription factor, important for skeletal muscle develop-
ment and expressed inmyogenic progenitors in the dermomyotome
of developing somites and in migratory muscle progenitors that
populate the limb buds. Down-regulation of Pax3 is essential to
ignite the myogenic program, including up-regulation of myogenic
regulators, Myf-5 and MyoD. MicroRNAs (miRNAs) confer robust-
ness to developmental timing by posttranscriptional repression of
genetic programs that are related to previous developmental stages
or to alternative cell fates. Here we demonstrate that the muscle-
speciﬁc miRNAs miR-1 and miR-206 directly target Pax3. Antagomir-
mediated inhibition of miR-1/miR-206 led to delayed myogenic
differentiation in developing somites, as shown by transient loss of
myogenin expression. This correlated with increased Pax3 and was
phenocopied using Pax3-speciﬁc target protectors. Loss ofmyogenin
after antagomir injection was rescued by Pax3 knockdown using
a splice morpholino, suggesting that miR-1/miR-206 control somite
myogenesis primarily through interactions with Pax3. Our studies
reveal an important role for miR-1/miR-206 in providing precision to
the timing of somite myogenesis. We propose that posttranscrip-
tional control of Pax3 downstream of miR-1/miR-206 is required to
stabilize myoblast commitment and subsequent differentiation.
Given thatmutually exclusive expressionofmiRNAs and their targets
is a prevailing theme in development, our ﬁndings suggest that
miRNA may provide a general mechanism for the unequivocal
commitment underlying stem cell differentiation.
chick and mouse embryo | progenitor-to-myoblast transition | locked
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Posttranscriptional regulation of gene expression by micro-RNAs (miRNAs) is an important feature of development.
miRNAs are short noncoding RNAs that bind to target sites
typically found in the 3′-UTR of messenger RNAs, resulting in
inhibition of translation and transcript degradation (1). The fre-
quently exclusive temporal or spatial expression of miRNAs and
their targets suggests that miRNAs confer accuracy to develop-
mental gene expression programs, thereby ensuring tissue identity
and supporting cell lineage decisions (2–4).
In skeletal muscle, miRNAs, including three highly related
miRNAs of the same family—miR-1-1, miR-1-2, and miR-206—
play important roles in proliferation, differentiation, and cell fate
speciﬁcation (5). The expression of these miRNAs is regulated by
skeletal muscle–speciﬁc bHLH transcription factors of the myo-
genic regulatory factor (MRF) family (6, 7), and some of their
targets have been investigated. In particular, miR-1 and miR-206
promote differentiation of C2C12 myoblasts by repression of
HDAC4, connexin 43, utrophin, follistatin-like, and a subunit of
DNA polymerase α (8–11). In addition, miR-1 and miR-206 facil-
itate differentiation of adult muscle stem cells through regulation of
the paired box transcription factor Pax7 (12). However, potential
roles ofmiR-1 andmiR-206 during embryonicmyogenesis have not
yet been identiﬁed, possibly due to their overlapping functions.
Deletion of miR-1-2 in mice leads to ventricular septal defects,
although skeletal muscle in these mice was found to be grossly
normal (13). Similarly, adult mice lacking miR-206 do not display
an overt muscle phenotype (14).
In vertebrate embryos, miR-206 expression is restricted to
skeletal myoblasts in somites, limb buds, and head muscles,
whereas miR-1 is expressed in developing heart as well (13).
Myogenic cells arising from embryonic somites give rise to skel-
etal muscles of the trunk and limbs, and skeletal myogenesis
serves as a paradigm for cell fate commitment in response to
extrinsic cues. Developmental signals that lead to activation of
MRFs, and thus myogenic commitment, have been well charac-
terized (15). Distinct regulatory networks underlie the formation
of different muscle groups (16). The hierarchy of transcription
factors controlling the myogenic program is also well understood.
Myogenic progenitors express the paired-box transcription factor
Pax3. In hypaxial muscle, Pax3 directly activates the muscle de-
termination gene Myf-5 (17), whereas in the epaxial dermomyo-
tome, Dmrt2 has been identiﬁed as a Pax3 target. Dmrt2 in turn
binds to the early epaxial enhancer of Myf-5, and this interaction
is required for the onset of myogenesis (18). MyoD, another key
regulator of myogenesis, has been identiﬁed as a direct target of
FoxO3 and Pax3 in myoblasts (19). Once activated, the MRFs di-
rect progenitor cells into the myogenic program, during which they
express myogenin and differentiate. Pax3 activates ectopic myo-
genesis in the neural tube of chicken embryos and in somite
explants (20), and the combined loss of Pax3 and Myf-5 abrogates
muscle development in the trunk (21). Pax3 expression in the
dermomyotome is down-regulated as cells move through the dor-
somedial and ventrolateral lips into the myotome, where they ex-
press MRFs (22, 23). Some Pax3-positive cells translocate directly
from the central dermomyotome into the myotome and contribute
to satellite cells, stem cells in adult muscle (24, 25). Migratory
muscle progenitors from the hypaxial dermomyotome require Pax3
in order to delaminate and migrate into limb buds (26, 27). In the
myotome and in dorsal and ventral limb muscle masses, up-regu-
lation of MRF expression correlates with down-regulation of Pax3,
which is necessary for terminal differentiation, because high Pax3
levels interfere with this process (28). During activation of adult
muscle stem cells, Pax3 is regulated by ubiquitination and protea-
somal degradation (29). How Pax3 is regulated during somite and
limb myogenesis in the embryo is not well understood, however.
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Here we used complementary in vitro and in vivo assays to
identify Pax3 as key target of miR-1/miR-206 in embryonic
myoblasts. Injection of antagomirs (30, 31) leads to an increase of
Pax3 and affects the timing of myoblast differentiation in de-
veloping somites. Pax3-speciﬁc target protector (TP)morpholinos
mimic the phenotype induced by antagomirs. Myogenesis is re-
stored in antagomir-injected somites by Pax3 knockdown, medi-
ated by electroporation of splice morpholinos. We propose that
after commitment, the complete posttranscriptional repression of
Pax3 is the key event through which miR-1/miR-206 promote
myogenic differentiation in the embryo.
Results
To conﬁrm the requirement of miRNAs for early myogenesis, we
used an available conditional allele to delete Dicer speciﬁcally in
skeletal muscle progenitors (32). Dicerﬂ/ﬂ females were crossed
with Dicerﬂ/+ males expressing cre-recombinase under the control
of the Pax3 promoter (33), resulting in loss of Dicer in Pax3-
expressing cells, including muscle progenitors in the dorsal somite.
Embryos were examined at E10.5, E11.5, and E12.5. Homozygous
Dicerﬂox/ﬂox/Cre offspring had grossly normal morphology com-
pared with their heterozygous littermates. Locked nucleic acid
(LNA) in situ hybridization showed that conditional loss of Dicer
led to loss of miR-206 in myoblasts (Fig. S1 D–F) compared with
the heterozygous littermates (Fig. S1A–C). This was ﬁrst apparent
in anterior somites of E10.5 and E11.5 mutant embryos (arrow-
heads in Fig. S1 D and E). At E12.5, miR-206 was absent in limb
muscles, in migratory hypaxial muscle precursors, and inmyoblasts
of tail somites (Fig. S1F). Loss of miR-206 was accompanied by
a delay in limb muscle differentiation, as shown by delayed myo-
genin expression (Fig. S1 J–L). Quantitative PCR (qPCR) on
dissected limbs of E12.5 and E13.5 embryos demonstrated that
loss of mature miR-206 and reduced myogenic differentiation in
Dicerﬂox/ﬂox/Cre mutant embryos was correlated with an increase in
Pax3 transcripts (Fig. S1M). These results conﬁrm that Dicer-
mediated biogenesis of miRNA is required for the appropriate
timing of myogenic differentiation, and that a delay in myogenesis
is associated with elevated levels of Pax3, a marker for myogenic
progenitor cells.
We previously used in situ hybridization to determine the onset
of miR-1 and miR-206 expression during somite development in
chicken embryos. LNA-containing probes discriminate between
miR-1 and miR-206. Both miRNAs were expressed in committed
myoblasts in the myotome, but miR-206 were expressed in almost
all somites by HH16, ∼24 h before miR-1 was detected at HH20
(7) (Fig. S2). This provided a window during which miR-206 was
the only member of the family present in somites of the de-
veloping chicken embryo. This was not the case in mice, where
miR-1 was weakly expressed in the ﬁrst four somites and miR-206
was absent at E9.5, but both miR-1 and miR-206 were equally
expressed in most somites by E10 (Fig. S2).
Expression of miRNAs and their targets is often mutually ex-
clusive in development. Thus, to examine the relationships of
miR-1 and miR-206 with Pax3 in vivo, we compared their spa-
tiotemporal expression during skeletal myogenesis (Fig. 1). In
somites, Pax3 transcripts were expressed in dorsomedial and
ventrolateral lips of the dermomyotome; miR-1 and miR-206
were not detected in the dermomyotome, but were robustly
expressed in committed myoblasts in the myotome (Fig. 1A). In-
terestingly, Pax3 and miR-1/miR-206 expression was overlapping
in the central myotome, which contains precursors of satellite
cells, stem cells in adult skeletal muscle (24); however, given that
our in situ hybridization did not allow single-cell resolution, we
could not determine whether Pax3 and miR-1/miR-206 are
expressed in the same cells. In developing limb muscles, expres-
sion of miR-206 at HH28 was correlated with down-regulation of
Pax3 in both forelimb and hindlimb muscles (Fig. 1B), whereas
miR-1 was only faintly expressed in HH28 hindlimbs. The pat-
terns suggested a possible role for miR-1/miR-206 in the complete
down-regulation of Pax3 within the myotome and limb muscle
masses, following myoblast commitment. Consistent with this,
ectopic expression of miR-206 in the dorsomedial dermomyo-
tome led to localized loss of Pax3 (Fig. 1C).
We used dual-luciferase reporter assays to examine whether
miR-1/miR-206 might regulate embryo myogenesis by targeting
Pax3. Two potential miR-1/miR-206 target sites in the Pax3 3′-
UTR, termed TS1 and TS2, are conserved in human, mouse, rat,
and chicken and have strong complementarity with the seed
regions of both miRNAs (Fig. 2A). We generated sensors con-
taining chicken Pax3 3′-UTR fragments downstream of ﬁreﬂy lu-
ciferase. Pax3 target sites were tested independently (TS1 or TS2)
and in a sensor containing both sites (TS1 + TS2). Dual-luciferase
assays showed that miR-1 and miR-206 directly target the Pax3 3′-
UTR through both predicted target sites (Fig. 2B). TS1 was
strongly down-regulated by miR-206, less so by miR-1, whereas
TS2 was equally well regulated by both miR-1 and miR-206.
Sensors containing both sites also were strongly down-regulated by
both miRNAs, with miR-1 beneﬁting more from the presence of
two sites. An unrelated miRNA not predicted to target Pax3, miR-
140, had no effect on Pax3 sensors (Fig. 2B). Finally, mutant
sensors containing point mutations within putative target sites
(TS1m and TS2m) demonstrated that the sites were required for
miRNA-mediated repression.
To investigate Pax3 regulation by miR-1/miR-206 in a cellular
context, we screened several cell lines using RT-qPCR and
Western and Northern blot analyses. We found that a glioma cell
line, RuGli (34), expressed robust levels of Pax3, but no miR-1/
miR-206. This allowed us to test the effects of miR-1/miR-206 on
endogenous Pax3. Transfection with miR-1 or miR-206 led to
reduced Pax3 transcript and protein expression, as shown by qPCR
and Western blot analysis; this was restored by antimiR-206
cotransfection (Fig. 2 C and D). Northern blot analysis of C2C12
cells showed that antimiR-206 affects expression of both miR-1
and miR-206 (Fig. S3).
Fig. 1. Expression of miR-1 and miR-206 is inversely correlated with Pax3 in
developing muscle. (A) Somite sections and schematics illustrating the dis-
tribution of miR-1, miR-206, and Pax3 in dermomyotome lips (dml, vll) and
myotome (m); probes are indicated above each panel. (B) Whole-mount
views of forelimbs (ﬂ) and hindlimbs (hl) at HH stages 24 and 28, hybridized
with Pax3, miR-1, or miR-206 probes as indicated. Pax3 transcripts detected
at HH24 were signiﬁcantly decreased by HH28, concomitant with increased
miR-206 expression at that stage. miR-1 was detected faintly in the HH28
hindlimb but strongly in the heart (ht) and somites. Stippled lines indicate
outline of limbs, and colored asterisks indicate equivalent regions. (C)
Double in situ hybridization showing ectopic miR-206 expression (red,
detecting GFP from miR-206 expression vector) leading to a loss of Pax3
transcripts (purple); a whole mount and a section are shown.














We previously showed that MRFs activate miR-1/miR-206 ex-
pression during embryogenesis, with Myf-5 being of particular
importance in both chick and mouse embryos (7). To examine the
in vivo function of miRNAs in somite myogenesis, we injected
2′O-methyl modiﬁed antisense RNA (antagomir) into pre-
segmented mesoderm of HH12–HH14 embryos. Presegmented
mesoderm was allowed to form somites, and embryos were har-
vested after 24 h or 48 h of incubation (Fig. 3 A–E). The antago-
mirs were designed to inhibit miR-1 or miR-206; an identical
antagomir-206 was previously shown to efﬁciently knock down
miRNA levels in chicken embryos (35). A scrambled antagomir
sequence was used as a negative control. Northern blot analyses
conﬁrmed the effects of antagomir-206 on miR-206 expression,
whichwas no longer detected after antagomir-206 treatment.miR-
1 expression was slightly affected by antagomir-206. Conversely,
antagomir-1 had no effect on miR-206 expression, but led to loss
of miR-1 (Fig. 3L). To examine whether miRNA inhibition affects
myogenic differentiation in antagomir-injected embryos, we per-
formed in situ hybridization for myogenin (Fig. 3 A–E). No myo-
genic phenotype was detected after 48 h of incubation; how-
ever, after 24 h, antagomir-206 or a combination of antagomir-206
and antagomir-1 led to complete or partial loss of myogenin ex-
pression in a signiﬁcant number of embryos [n = 99/161 (61.5%)
and n = 67/102 (65.6%); P < 0.001; Fig. 3 B, D, and E]. Micro-
injection of antagomir-1 affected myogenin expression in 12% of
embryos (n = 13/109; Fig. 3 C and E). Injection of scrambled
antagomir had no effect on somite myogenesis (n= 111; Fig. 3A).
These ﬁndings suggest coordinated effects of miR-1 and miR-206
acting through the same seed sequence, which is important for
the timely progression of myogenic progenitors into a differ-
entiated state.
To corroborate the results from in situ hybridization, we used
antibodies against Pax3 (red) and sarcomeric myosin (MF20,
green), which label myogenic progenitors and differentiating
myoblasts, respectively. This conﬁrmed the effects of antagomir-
206 on myogenic differentiation (Fig. 3 F, F′, and G and Fig. S4).
Sectioned and stained embryos had fewer MF20-positive cells on
the injected side (Fig. 3F), and Pax3-positive mesenchymal cells
were detected in the myotome after antagomir-206 injection (red,
Fig. 3F′ and Fig. S4).
We used real-time qPCR and Western blot analysis to further
examine the differences detected by in situ hybridization and
immunohistochemistry. In dissected and pooled somites, we de-
tected increased levels of Pax3 (Fig. 3H) and decreased levels of
myogenin (Fig. 3I) after antagomir-206 injection compared with
contralateral controls or scrambled antagomir-treated somites. In
antagomir-1–injected somites, myogenin transcript levels were
reduced by 20%, but there was no detectable change in Pax3,
likely because only a small number of embryos injected with
antagomir-1 showed any loss of myogenin, thus diluting any effect
(Fig. 3E). Importantly, we did not expect to see any effect on Pax3
expression levels in the epithelial dermomyotome, given the lack
of miR-1/miR-206 expression there (Fig. 1A); thus, the changes
that we observed should be due to ectopic expression of Pax3 in
myotome cells. Western blot analyses of dissected somites con-
ﬁrmed the effect of antagomir-206 on Pax3 protein, which was
increased in injected somites (Fig. 3K). Conversely, Western blot
analyses of antagomir-1-injected somites showed no effect on
Pax3 (Fig. 3J), most likely for the reasons described above. Ex-
pression levels of Pax7 apparently remained unchanged (Fig. 3 K
and J). These ﬁndings indicate that relatively small increases in
Pax3 transcript and protein levels have a dramatic effect on the
timing of myogenesis.
Because miRNAs have multiple targets, we investigated wheth-
er the interaction of miR-1/miR-206 speciﬁcally with Pax3 is the
key event. For this, we made use of TPs, a powerful in vivo tool for
investigating individual miR–target site interactions (36). Distinct
TP morpholinos (TP1 and TP2, both FITC-labeled) were
designed to protect miR-1/miR-206 target sites in the Pax3
3′-UTR (Fig. 4A). Cotransfection of TP1 and TP2 strongly
inhibited the effect of miRNA on luciferase sensor constructs
(Fig. S5). A TP1–TP2 mixture or a control morpholino was
electroporated into presegmented mesoderm of HH14–HH16
chicken embryos. After 24 h, injected and noninjected contra-
lateral somites were analyzed by Western blot (Fig. 4B) or qPCR
(Fig. 4C). Targeted delivery of TP1/TP2 led to a detectable in-
crease of Pax3 in injected somites compared with controls, con-
sistent with the idea that TP1/TP2 interfere with the ability of
miR-1/miR-206 to interact with the Pax3 3′-UTR. In addition,
qPCR (Fig. 4C) and in situ hybridization (Fig. 4D) showed
a dramatic reduction of myogenin expression in injected somites.
Thus, antagomir injections (Fig. 3) and Pax3-speciﬁc TPs resulted
in similar phenotypes, indicating that efﬁcient repression of Pax3
by miR-1/miR-206 is crucial for timely progression of myogenic
differentiation. This was conﬁrmed by targeted misexpression of
Pax3, which led to localized loss of myogenin expression in the
myotome (Fig. 4E, Upper), demonstrating that persistent Pax3
expression in vivo is incompatible with myogenic differentiation.
In contrast, morpholino-mediated knockdown of Pax3 at the same
stage did not affect myogenesis (Fig. 4E, Lower).
Finally, we examined whether knockdown of Pax3 expression
using morpholinos rescued the antagomir-206–induced loss of
myogenin. We electroporated FITC-labeled Pax3 splice morpho-
lino or control morpholino into somites previously injected with
antagomir-206 (Fig. 4F, Upper). The morpholino is complemen-
tary to the exon 1–intron 1 splice junction (Fig. 4G). Western blot
analysis of dissected and pooled somites showed a decrease of
Fig. 2. The 3′-UTR of Pax3 is regulated by miR-1 and miR-206. (A) Alignment
of target sites TS1 and TS2 with miR-1 and miR-206; Materials and Methods
provides the genomic positions. (B) Normalized luciferase activity shown for
Pax3–3′-UTR sensor constructs cotransfected with miR-1, miR-206, or miR-140
as indicated by (+). Activity was plotted relative to control (no miRNA).
Experiments were repeated four times with triplicate samples and two in-
dependent DNA plasmid preparations. Error bars represent SE (n = 12). The
constructs used are indicated above the graphs; TSm represents constructs
with mutant target sites. (C) qPCR of Pax3 expression in RuGli cells. Pax3
transcript levels in mock-transfected control cells (lane 1) were reduced after
transfection of miR-206 (lane 3) and miR-1 (lane 4). Cotransfection of anti-
miR-206 (AM) with miR-206 (lane 2) restored Pax3 expression. (D) Western
blot analysis showing reduced Pax3 protein in RuGli cells transfected with
miR-206 (lane 3) and miR-1 (lane 4). Protein levels were unaffected after
cotransfection of antimiR-206 (AM) with miR-206 (lane 2).
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Pax3 protein after splice morpholino electroporation compared
with controls (Fig. 4H). In situ hybridization showed a rescue of
myogenin expression in regions of the somite that received the
Pax3 splice morpholino (red), suggesting that miR-206 mediates
its effect primarily via targeting of Pax3. In embryos injected with
antagomir-206 followed by control morpholino electroporation,
the loss of myogenin was not prevented (Fig. 4F, Lower).
Discussion
The miRNAs miR-1 and miR-206 have important functions in
myogenesis. Their expression is positively regulated by MRFs (6,
7), and they have been shown to regulate a number of transcripts
important for muscle biology (8–11). However, despite their
striking, myotome-speciﬁc expression in developing somites, the
role of miR-1/miR-206 in skeletal muscle development has not
been resolved. Mice lacking either miR-1-2 or miR-206 have no
overt phenotype in adult muscle (13, 14), most likely due to
functional redundancy, given that these miRNAs have common
targets. Here we made use of the accessibility of the chicken
embryo for in vivo microinjection, which allowed us to inhibit
miRNA function using antagomirs. We focused on a 24-h period
in which miR-206 is the only family member expressed in somites
to show that antagomirs inhibiting miR-1/miR-206 led to delayed
myogenic differentiation (Fig. 3).We have provided evidence that
this is due to the failure of complete down-regulation of Pax3.
Inhibition of miRNA function in somites by antagomir-206 in-
jection followed by quantitative analyses conﬁrmed an increase in
Pax3 expression (Fig. 3H and K) accompanied by delayed muscle
differentiation (Fig. 3B,E, and F). The effects of miR-1 inhibition
in vivo were similar, although less strong (Fig. 3 C and E). This
could be due to the activity of miR-206 in these somites, which,
based on Northern blot analysis, was not affected by antagomir-1
(Fig. 3L). We speculate that in chicken embryos, miR-206 is the
primary regulator of skeletal myogenesis and miR-1 has a sec-
ondary role, with both miRNAs providing robustness to skeletal
muscle differentiation, presumably through similar mechanisms.
This is in agreement with the earlier expression of miR-206 in
both somites and limbs (7) (Fig. 1B and Fig. S2 A–D). During
mouse embryogenesis, within a few hours of detection of miR-1 in
anteriormost somites at E9.5, both miRNAs were expressed in
almost all somites along the axis by E10 (Fig. S2 E–H). This
suggests that miR-1 andmiR-206 likely have redundant functions,
consistent with the observation that genetic deletion of either
miR-1-2 or miR-206 in mice does not result in an overt skeletal
muscle phenotype. This is in contrast to cardiogenesis, where
deletion of miR-1-2 results in ventricular septal defects (13, 14).
After miR-1/miR-206 inhibition, the delay in muscle differ-
entiation was transient, suggesting that additional mechanisms,
potentially independent of miRNA, ensure the progression of
myogenic differentiation. Functional interference experiments
have indicated that miR-1 and miR-206 control the timing of the
progenitor-to-myoblast transition during embryonic myogenesis,
consistent with the view that miRNAs confer accuracy to de-
velopmental programs (2–4) (Fig. 5).
Pax3 sensors containing two conserved target sites were efﬁ-
ciently targeted by miR-1 and miR-206 (Fig. 2B), and endoge-
nous Pax3 expression was regulated by miRNA at the level of
both protein and RNA (Fig. 2 C and D), suggesting effects on
both mRNA stability and repression of protein translation. The
Pax3 TS1 site has greater complementarity to miR-206 compared
with miR-1, and was more strongly affected by miR-206 (Fig. 2A).
In addition, miR-206 seemed to be maximally effective in the
presence of only one binding site, whereas miR-1 was much more
effective in the presence of both TS1 and TS2. Interestingly, only
a small number of targets have more than one putative target site
for any given miRNA (2), and it is possible that effective down-
regulation is enhanced by cooperation between sites.
Although miR-1 and miR-206 have been shown to target sev-
eral genes involved in myogenesis in vitro and in adult muscles
(8–12), our results show that interference with miRNA function
or biogenesis at the time of myoblast commitment leads to
changes in Pax3 expression in both somites (Fig. 3H) and limb
buds (Fig. S1M). In somites, these changes are masked by con-
tinued expression of Pax3 in the dermomyotome, which is un-
affected by antagomir-206 injection (Fig. 3F), because miR-206
expression is restricted to committed myoblasts in the myotome
(Fig. 1). However, we detected a reproducible and signiﬁcant
increase in Pax3 levels using qPCR andWestern blot analyses, and
Pax3 increase was correlated with dramatic (albeit transient)
changes in the muscle differentiation markers myogenin and
myosin heavy chain (Fig. 3H–K). In addition, we observed ectopic
Pax3 staining in cells delaminating from the dermomyotomal
sheet and moving into the myotome to become mesenchymal
muscle cells (37) (Fig. 3 F and F′ and Fig. S4); however, this was
close to the limit of detection by immunohistochemistry, likely
because the primary mechanism of Pax3 regulation is at the level
Fig. 3. Delayed myogenic differentiation after antagomir-
mediated inhibition demonstrates a requirement for miR-1
and miR-206 activity. Antagomirs injected into presomitic
mesoderm of HH12–14 embryos are indicated above each
panel. Myogenic differentiation was assessed after 24 h by in
situ hybridization with a myogenin probe. (A–D) Injection of
scrambled antagomir had no effect (A); however, injection of
antagomir-206 (B) or a 1:1 mixture of antagomir-206 and
antagomir-1 (D) led to a loss of myogenin expression. Injection
of antagomir-1 also affected myogenic differentiation (C). (E)
Quantiﬁcation of phenotypes observed. (F, F′, and G) Sections
immunostained for Pax3 in the dermomyotome (red) and
MF20 in the myotome (green) conﬁrmed the inhibition of
myogenic differentiation after antagomir-206 injection (F)
compared with control embryos (G). F′ is a higher-magniﬁcation
view of F illustrating the increased number of Pax3-positive
cells in the myotome (white arrowheads). Fewer myosin heavy
chain (MF20)-positive cells were detected on the injected side,
indicated by an asterisk, see also Fig. S4. (H and I) qPCR
demonstrating the opposite effects on Pax3 and myogenin
transcript levels in antagomiR-206 injected somites. (J and K)
Western blots of dissected somites treated as indicated re-
vealing increased Pax3 protein levels in antagomiR-206 injec-
ted somites with no change apparent on Pax7 protein levels.
(L) Northern blot showing that antagomiR-1 speciﬁcally
affects miR-1 and antagomiR-206 affects miR-206.














of transcriptional repression (Figs. 1A and 5), which is not af-
fected by antagomir. Down-regulation of Pax3 is also concomitant
with up-regulation of MRFs, which themselves are involved in
activation of miRNA expression (6, 7). Thus, miR-1 and miR-206
reinforce negative regulation of Pax3 expression and make a sig-
niﬁcant contribution to the complete silencing of Pax3, which
leads to the timely expression of myogenin or sarcomeric myosin
in committed myoblasts (Figs. 3 and 5).
We have shown that miR-1 and miR-206 act primarily through
Pax3, as demonstrated by the fact that blocking this interaction
with speciﬁc TPs also led to loss of myogenin in affected cells
(Fig. 4 C and D). Furthermore, myogenin expression was rescued
by Pax3 splice morpholinos in antagomir-206–injected somites
(Fig. 4 F and H). The Pax3 morpholino by itself had no effect on
myogenin expression (Fig. 4E, Lower), consistent with the lack of
a somitic muscle phenotype in Pax3 mutant mice (22, 27). Thus,
our data show that precise and robust developmental timing
during myogenesis requires miR-1/miR-206, with Pax3 as a cru-
cial target in embryonic myoblasts.
The importance of Pax3 in myogenesis is well established (20,
21, 38). It is expressed in proliferating muscle progenitors, before
expression of MRFs, and down-regulated as myogenesis proceeds
(22, 23). Interestingly, a population of cells in the central myo-
tome, which contribute to adult muscle stem cells (24), retain
Pax3 expression (Fig. 1A) to promote their survival and myotome
growth (39).Whether or not these cells coexpress miR-1 andmiR-
206 remains to be determined; current in situ detection methods
with LNAprobes do not allow single-cell resolution. The behavior
of adult muscle stem cells—particularly their proliferation, dif-
ferentiation, and apoptosis—is regulated by Pax3 and the closely
related Pax7. The protein levels of Pax3/7 were recently demon-
strated to be tightly regulated by miRNAs, including miR-27b and
miR-206 (12, 40, 41). Thus, embryonic myoblasts and adult
muscle stem cells require mechanisms to tightly regulate Pax3/
Pax7 activity. We suggest that miR-1 and miR-206 are responsible
for regulation of Pax3 in newly committed myoblasts to control
the timely progression of embryo myogenesis. This aspect of their
function remains important in adult muscle stem cells.
Materials and Methods
DNA Constructs, Transfections, and Luciferase Assay. Sensors contained chick
Pax3 3′-UTR fragments in a modiﬁed pGL3 vector (Promega; Pax3 TS1 sensor: nt
906–1,106; Pax3 TS2 sensor: nt 51–657; Pax3 TS1+2 sensor: nt 51–1,106). Inmutant
constructs, a BamHI site introduced point mutations within target sites. Chick
dermal ﬁbroblast cells (DF1 cells) were transfected with 200 ng of sensor with or
without miR-206 or miR-1 (50 nM) (Sigma-Aldrich), using Lipofectamine 2000
(Invitrogen) in 96-well plates. miR-1 duplexes (5′-UGGAAUGUAAAGAAGUAU-
GUA-3′ and 5′-CAUACUUCUUUAUAUGCCCAUA-3′) and miR-206 duplexes (5′-
UGGAAUGUAAGGAAGUGUGUGG-3′ and 5′-ACAUGCUUCUUUAUAUCCCCAUA-
3′) were identical to endogenous miRNAs. pGL3 vector without 3′-UTR or with
mutant 3′-UTRs, or transfection of unrelated miR-140, served as a negative con-
trol. Transfections had triplicate samples and were repeated four times using in-
dependent plasmid preparations. Fireﬂy and renilla luciferase activities were
measured after 48 h using a multilabel counter (Victor2; Perkin-Elmer), and rela-
tive activities were calculated. For overexpression of miR-206, we constructed
Fig. 4. miRNA affects somite myogenesis predominantly via
Pax3. (A) FITC-labeled TP MO, designed to prevent miR-1/miR-
206 interactions with both target sites in the Pax3 3′-UTR, were
electroporated. After overnight incubation, somites were
microdissected. (B–D) Western blot (B) and qPCR (C) demon-
strated increases in Pax3 protein and transcripts after electro-
poration with TP1 plus TP2 compared with contralateral
noninjected somites or somites electroporated with control
morpholinos (MO). qPCR (C) and in situ hybridization (D) dem-
onstrated a corresponding loss ofmyogenin expression (Upper);
myogenin expression in control morpholino-injected somites
was comparable to that in noninjected somites from the op-
posite side (Lower). (E–H) Electroporation of Pax3/GFP expres-
sion vectors (red) led to localized loss of myogenin (blue),
consistent with the concept that elevated Pax3 levels are in-
compatible with differentiation (Upper). (E and G) Electro-
poration of Pax3 splice morpholinos (red) had no effect on
myogenin expression (blue; Lower). (H) Western blot analysis
conﬁrmed reduced Pax3 expression in somites after Pax3 MO
electroporation. (F) Cotransfection of Pax3 splice-MO (red) res-
cued antagomiR-206–induced loss of myogenin transcripts and
restored normal expression ofmyogenin (blue;Upper), whereas
control morpholino (red) did not rescue the antagomir-206
mediated inhibition of myogenin expression (blue; Lower).
Fig. 5. Model illustrating that the complete silencing of Pax3 in committed
myoblasts confers robustness to developmental timing of differentiation;
see Discussion for details.
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a vector encoding a short-hairpin precursor. Northern blot analysis demonstrated
production of mature miR-206 was produced. A mouse Pax3 expression vector
(MRC Geneservice) was used for overexpression.
Cell Culture, Western Blot Analysis, and Real-Time qPCR. Rat RuGli glioblastoma
cells inDMEM,10%FBS,and1%pen/strepweretransfectedwithmiR-206ormiR-1
(50 nM; Sigma-Aldrich) with and without anti–miR-206 (50 nM; Ambion) using
Lipofectamine 2000. Mock-transfected cells were used as negative controls.
Proteinwas extractedat 48hafter transfection following standardprotocols, and
20 μg was run on 8% polyacrylamide gels and blotted onto nitrocellulose using
a semidry blotter (Biorad). Primary antibodies Pax3, Pax7 (1:500 dilution; De-
velopmental Studies HybridomaBank), and actin (1:1,000; Abcam) and secondary
antibodies (Jackson Laboratories) were applied for 1 h at room temperature.
RNA was extracted from cells, somites, or limbs using TRIzol (Invitrogen).
cDNA synthesis was done using SuperScript II (Invitrogen). Predesigned
TaqMan probes were used with the Applied Biosystems 7500 Fast Real-Time
PCR system following the manufacturer’s protocols. Data analysis was per-
formed with Applied Biosystems SDS version 2.0.
In Situ Hybridization and Immunohistochemistry. Whole-mount in situ hybrid-
ization using double-labeled LNA oligos (mercury; Exiqon) or anti-sense RNA
probeswascarriedoutasdescribedpreviously (7).Embryoswereﬁxed in4%PFA,
embedded in parafﬁn, sectioned, and immunostained as described previously
(42). The MF20 and PAX3 antibodies were obtained from the Developmental
Studies Hybridoma Bank developed under the auspices of the National Institute
of Child Health and maintained by the University of Iowa.
Injection of Antagomir, Target Protectors, and Antisense Morpholinos. Anta-
gomirsweredesignedbasedonpreviouslypublishedmethods (30, 31).Allbases
were replaced by 2′O-methyl bases; thiol bonds replaced phosphodiester
bonds between bases 1 and 2, 2 and 3, 19 and 20, 20 and 21 and 21 and 22; and
a 3′ cholesterol moiety (Dharmacon) was included. Scrambled sequences were
used as controls. For injections, Fast Green (0.05%) was added to the anta-
gomir, to a ﬁnal concentration 100 μM. Embryos were injected into pre-
segmentedmesoderm as described previously (35), and the number of somites
was recorded as ’n’. Embryoswereharvested after 24 h, and somites n+1 to n+4
were dissected and lysed (42). Corresponding somites from the uninjected side
were used as controls, Between 20 and 25 treated embryos were pooled for
Western blot analysis using 20 μg of protein. Blots were repeated three times
with somites from independent experiments.
Pax3 morpholino (CCCTCCTCCTGCCCTCACCTTCCAA) was designed to tar-
get both Pax3 splice variants. Control morpholino (CCTCTTACCTCAGTTA-
CAATTTATA)wasdesigned tonot target anyknowngene. TPs complementary
to miR-1/miR-206 target sites in the Pax3 3′-UTR were Pax3 TP1 (TATAAC-
GACGGACCGTTTTGTAAGG) and Pax3 TP2 (CTCTCCGTCTTGTGTTTATGTAA-
GG). Morpholinos were 3′ ﬂuorescein-labeled (Gene Tools), injected into
somites at HH14-16, and electroporated using 6 × 20 ms pulses of 20V. Em-
bryos were harvested after 24 h.
Dicer Conditional Null Mice. Dicer ﬂoxed (Dicerﬂ/ﬂ) mice and Pax3 Cre knock-in
strains have been described previously (32, 33). Litters were genotyped by PCR
of genomic DNA obtained from embryonic yolk sacs using the following pri-
mers: Dicer-F, AGTGTAGCCTTAGCCATTTGC; Dicer-R, CTGGTGGCTTGAGGAC-
AAGAC; CreORF-F, ATCCGAAAAGAAAACGTTGA; and CreORF-R, ATCCAGG-
TTACGGATATAGT.
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